Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: Irreversible inhibition of infectivity

Journal of Virology

Volumn 71, Issue 11, 1997, Pages 8808-8820

  Hoffman, Lucas R ^a   Kuntz, I D ^a,b   White, Judith M ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4',5' DIIODOFLUORESCEIN; ANTIVIRUS AGENT; BENZOQUINONE DERIVATIVE; C 22; HYDROQUINONE DERIVATIVE; TERT BUTYLHYDROQUINONE; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL CULTURE; COMPUTER PROGRAM; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG EFFECT; DRUG STRUCTURE; INFLUENZA VIRUS; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS RESISTANCE;

EID: 0030753409     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.11.8808-8820.1997     Document Type: Article

References (59)

1. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1995. Short protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
2. Baker, D., and D. A. Agard. 1994. Influenza hemagglutinin: kinetic control of protein function. Structure 2:907-910.
3. Bernstein, F. C., T. F. Koetzle, G. J. B. Williams, J. Meyer, E. F., M. C. Brice, J. R. Rodgers, O. Kennard, T. Shimanouchi, and M. Tasumi. 1977. The protein data bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 112:535-542.
4. Bethell, R. C., N. M. Gray, and C. R. Penn. 1995. The kinetics of the acid-induced conformational change of influenza virus haemagglutinin can be followed using 1,1′-bis(4-anilino-5-naphthalenesulphonic acid). Biochem. Biophys. Res. Commun. 206:355-361.
5. Bodian, D. 1992. Ph.D. thesis. University of California, San Francisco.
6. Bodian, D. L., R. B. Yamasaki, R. L. Buswell, J. F. Stearns, J. M. White, and I. D. Kuntz. 1993. Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry 32:2967-2978.
7. Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43.
8. Carr, C. M., and P. S. Kim. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73:823-832.
9. Connolly, L., K. Zingler, and J. A. T. Young. 1994. A soluble form of a receptor for subgroup A avian leukosis and sarcoma viruses (ALSV-A) blocks infections and binds directly to ALSV-A. J. Virol. 68:2760-2764.
10. Daniels, R. S., A. R. Douglas, J. J. Skehel, M. D. Waterfield, I. A. Wilson, and D. C. Wiley. 1983. Studies of the influenza virus haemagglutinin in the PH5 conformation, p. 1-7. In W. G. Laver (ed.), The origin of pandemic influenza viruses. Elsevier Science Publishing Co., Inc., New York, N.Y.
11. Daniels, R. S., J. C. Downie, A. J. Hay, M. Knossow, J. J. Skehel, M. L. Wang, and D. C. Wiley. 1985. Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 40:431-439.
12. Desjarlais, R., R. Sheridan, G. Seibel, J. Dixon, I. Kuntz, and R. Venkataraghavan. 1988. Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. J. Med. Chem. 31:722-729.
13. Doms, R. W., M.-J. Gething, J. Henneberry, J. White, and A. Helenius. 1986. Variant influenza virus hemagglutinin that induces fusion at elevated pH. J. Virol. 57:603-613.
14. Ellens, H., S. Doxsey, J. S. Glenn, and J. M. White. 1989. Delivery of macromolecules into cells expressing a viral membrane fusion protein. Methods Cell Biol. 31:155-176.
15. Ferrin, T. E., C. C. Huang, L. E. Jarvis, and R. Langridge. 1988. The Midas display system. J. Mol. Graphics 6:13-27.
16. Gaush, C. R., and T. F. Smith. 1968. Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl. Microbiol. 16:588-594.
17. Gilbert, J. M., L. D. Hernandez, J. W. Balliet, P. Bates, and J. M. White. 1995. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein. J. Virol. 69:7410-7415.
18. Godley, L., J. Pfeifer, D. Steinhauer, B. Ely, G. Shaw, R. Kaufmann, E. Suchanek, C. Pabo, J. J. Skehel, D. C. Wiley, and S. Wharton. 1992. Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity. Cell 68:635-645.
19. Gschwend, D., and I. Kuntz. 1996. Orientational sampling and rigid-body minimization in molecular docking revisited: on-the-fly optimization and degeneracy removal. J. Comput.-Aided Mol. Des. 10:123-132.
20. Hernandez, L., and J. M. White. Unpublished observations.
21. Hernandez, L. D., L. R. Hoffman, T. G. Wolfsberg, and J. M. White. 1996. Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev. Biol. 12:627-661.
22. Hoffman, L. 1996. Ph.D. thesis. University of California, San Francisco.
23. Houck, P., M. Hemphill, S. LaCroix, D. Hirsch, and N. Cox. 1995. Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use. Arch. Intern. Med. 155:533-537.
24. Huang, R. T. C., R. Rott, and H.-D. Klenk. 1981. Influenza viruses cause hemolysis and fusion of cells. Virology 110:243-247.
25. Kemble, G. W., D. L. Bodian, J. Rosé, I. A. Wilson, and J. M. White. 1992. Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin. J. Virol. 66:4940-4950.
26. Kemble, G. W., T. Danieli, and J. M. White. 1994. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell 76:383-391.
27. Krumbiegel, M., A. Hermann, and R. Blumenthal. 1994. Kinetics of the low pH-induced conformational changes and fusogenic activity of the influenza hemagglutinin. Biophys. J. 67:2355-2360.
28. Lambert, D., S. Barney, A. Lambert, K. Guthrie, R. Medinas, D. Davis, T. Bucy, J. Erickson, G. Merutka, and S. J. Pettesay. 1996. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA 93:2186-2191.
29. Luo, G., R. Colonno, and M. Krystal. 1996. Characterization of a hemagglutinin-specific inhibitor of influenza A virus. Virology 226:66-76.
30. Melikyan, G. B., J. M. White, and F. S. Cohen. 1995. GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes. J. Cell Biol. 131:679-691.
31. Meng, E., B. Shoichet, and I. Kuntz. 1992. Automated docking with grid-based energy evaluation. J. Comp. Chem. 13:505-524.
32. Qiao, H., S. Pelletier, L. Hoffman, J. Hacker, and J. White. Submitted for publication.
33. Service, R. 1997. Researchers seek new weapon against the flu. Science 275:756-757.
34. Shangguan, T., D. Alford, and J. Bentz. 1996. Influenza virus-liposome lipid mixing is leaky and largely insensitive to the material properties of the target membrane. Biochemistry 35:4956-4965.
35. Shoichet, B., D. Bodian, and I. Kuntz. 1992. Molecular docking using shape descriptors. J. Comp. Chem. 13:380-397.
36. Shoichet, B., and I. Kuntz. 1991. Protein docking and complementarity. J. Mol. Biol. 221:327-346.
37. Skehel, J. J., P. M. Bayley, E. B. Brown, S. R. Martin, M. D. Waterfield, J. M. White, I. A. Wilson, and D. C. J. Wiley. 1982. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc. Natl. Acad. Sci. USA 79:968-972.
38. Staschke, K. A., J. M. Colacino, A. J. Baxter, G. M. Air, A. Bansal, W. J. Hornback, J. E. Munroe, and W. G. Laver. 1995. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en. Virology 214: 642-646.
39. Stegmann, T., F. P. Booy, and J. Wilschut. 1987 Effects of low pH on influenza virus. Activation and inactivation of the membrane fusion capacity of the hemagglutinin. J. Biol. Chem. 262:17744-17749.
40. Stegmann, T., W. Morselt, J. Scholma, and J. Wilschut. 1987. Fusion of influenza virus in an intracellular acidic compartment measured by fluorescence dequenching. Biochim. Biophys. Acta 904:165-170.
41. Steinhauer, D. A., N. K. Sauter, J. J. Skehel, and D. C. Wiley. 1992. Receptor binding and cell entry by influenza viruses. Semin. Virol. 3:91-100.
42. Steinhauer, D. A., S. A. Wharton, J. J. Skehel, D. C. Wiley, and A. J. Hay. 1991. Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc. Natl. Acad. Sci. USA 88: 11525-11529.
43. Tobita, K., A. Sugiura, C. Enomoto, and M. Furuyama. 1975. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med. Microbiol. Immunol. 162:9-14.
44. Tomassini, J. E., M. E. Davies, J. C. Hastings, R. Lingham, M. Mojena, S. L. Raghoobar, S. B. Singh, J. S. Tkacz, and M. A. Goetz. 1996. A novel antiviral agent which inhibits the endonuclease of influenza viruses. Antimicrob. Agents Chemother. 40:1189-1193.
45. 2 ion channel activity by BL-1743, a novel inhibitor of influenza A virus. J. Virol. 70:4246-4252.
46. Watowich, S. J., J. J. Skehel, and D. C. Wiley. 1994. Crystal structures of influenza virus hemagglutinin in complex with high-affinity receptor analogs. Structure 2:719-731.
47. +-induced insertion of the influenza hemagglutinin HA2 N-terminal segment into the viral membrane. J. Biol. Chem. 269:18353-18358.
48. Weis, W. I., A. T. Bruenger, J. J. Skehel, and D. C. Wiley. 1990. Refinement of the influenza virus hemagglutinin by simulated annealing. J. Mol. Biol. 212:737-761.
49. Weis, W. I., S. C. Cusack, J. H. Brown, R. W. Daniels, J. J. Skehel, and D. C. Wiley. 1990. The structure of a membrane fusion mutant of the influenza virus haemagglutinin. EMBO J. 9:17-24.
50. Wharton, S. A., R. B. Belshe, J. J. Skehel, and A. J. Hay. 1994. Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine. J. Gen. Virol. 75:945-948.
51. Wharton, S. A., L. J. Calder, R. W. H. Ruigrok, J. J. Skehel, D. A. Steinhauer, and D. C. Wiley. 1995. Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO J. 14:240-246.
52. White, J. M. 1994. Fusion of influenza virus in endosomes: role of the hemagglutinin, p. 281-301. In E. Wimmer (ed.), Cellular receptors for animal viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
53. White, J. M., and I. A. Wilson. 1987. Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J. Cell Biol. 105:2887-2896.
54. Wild, C. T., D. C. Shugars, T. K. Greenwell, C. B. McDanal, and T. J. Matthews. 1994. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91:9770-9774.
55. Wiley, D. C., and J. J. Skehel. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56:365-394.
56. Wilson, I. A., J. J. Skehel, and D. C. Wiley. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289:366-372.
57. Wintermeyer, S., and M. Nahata. 1995. Rimantadine: a clinical perspective. Ann. Pharmacother. 29:299-310.
58. Woods, J. M., R. C. Bethell, J. A. V. Coates, N. Healy, S. A. Hiscox, B. A. Pearson, D. M. Ryan, J. Ticehurst, J. Tilling, S. M. Walcott, and C. R. Penn. 1993. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Chemother. 37:1473-1479.
59. Xu, X., E. Rocha, H. Regnery, A. Kendai, and N. Cox. 1993. Genetic and antigenic analyses of influenza A(H1N1) viruses, 1986-1991. Virus Res. 28:37-45.